Avidity Biosciences, LLC is a biopharmaceutical company pioneering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs)™. Their proprietary AOC platform is designed to combine the specificity of monoclonal antibodies with the precision of oligonucleotide therapies to target the root cause of diseases previously untreatable with RNA therapeutics. Avidity is focused on rare muscle diseases and other serious conditions, with a mission to profoundly improve people's lives by revolutionizing the delivery of RNA therapeutics.
The headquarters serves as the primary center for research and development, clinical operations, corporate strategy, and administrative functions.
Features state-of-the-art laboratory facilities for drug discovery and development, modern office spaces designed for collaboration, and proximity to leading research institutions and talent.
The work culture at Avidity's headquarters is characterized by a strong emphasis on scientific innovation, collaboration, and a patient-centric approach. It fosters a dynamic environment where employees are driven by the potential to make a significant impact on treating rare diseases.
The La Jolla headquarters is strategically significant due to its location in a leading biotech cluster, enabling access to a skilled workforce, research collaborations, and essential infrastructure for advancing their AOC platform.
Avidity Biosciences's global presence is primarily manifested through its clinical trial activities, which are conducted across various countries. They collaborate with international research institutions and investigators to advance their pipeline of AOC therapeutics. As their programs mature, their global operational footprint related to regulatory affairs, manufacturing, and potential commercialization is expected to expand.
10975 North Torrey Pines Road, Suite 150
La Jolla
CA
USA
Address: Information not publicly listed; operations primarily centralized in La Jolla. Any additional sites would likely support specific research or clinical operations.
A hypothetical East Coast presence, such as in Research Triangle Park, would offer access to another significant biotech hub, potentially facilitating clinical trial site management, collaborations, or talent acquisition for specific functions.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Avidity Biosciences, Inc.' leadership includes:
Avidity Biosciences, Inc. has been backed by several prominent investors over the years, including:
Avidity Biosciences has seen key leadership changes aimed at strengthening its clinical development and technical operations capabilities as it advances its pipeline.
Discover the tools Avidity Biosciences, Inc. uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Avidity Biosciences typically uses a standard corporate email format. The most common format observed is the first initial followed by the last name. Variations might exist but this is a strong primary pattern.
[first_initial][last]@aviditybiosciences.com
Format
jdoe@aviditybiosciences.com
Example
90%
Success rate
GlobeNewswire • May 21, 2024
Avidity reported positive initial data from the Phase 1/2 FORTITUDE™ trial of del-brax, also known as AOC 1020, in adults with FSHD. The data showed unprecedented targeted delivery of RNA to muscle, substantial reductions in DUX4 regulated genes, and trends of clinical benefit....more
GlobeNewswire • May 7, 2024
Avidity Biosciences provided an update on its pipeline programs, including AOC 1001 for DM1, AOC 1020 for FSHD, and AOC 1044 for DMD. The company highlighted upcoming data readouts and its strong financial position to support ongoing development....more
GlobeNewswire • March 5, 2024
Avidity announced plans to present new, long-term data from the MARINA-OLE™ trial for AOC 1001 in adults with DM1, showcasing sustained benefits including improvements in myotonia, muscle strength, and patient-reported outcomes....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Avidity Biosciences, Inc., are just a search away.